Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01645319 · ClinicalTrials.gov registry record
Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
A clinical trial of Open Angle Glaucoma, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- 2,597
- Enrollment target
- 1
- Study location
NCT01645319: Completed study of Open Angle Glaucoma, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT01645319 is a study of Open Angle Glaucoma that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 2,597 participants, above the 242-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (973% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01645319, a study of Open Angle Glaucoma, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- 2,597 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of the study are: 1. To compare the proportion of patients who achieve a successful response to treatment (reduction in Intraocular Pressure (IOP) of \>15%) between patients treated with laser surgery (including argon laser trabeculectomy, and selective laser trabeculoplasty) with patients receiving additional medications, at 1-year post-treatment initiation. 2. To compare the proportion of patients who achieve a successful response to treatment (reduction in IOP of \>15%) between patients treated with other procedures (including incisional surgery, drainage device procedures, and other glaucoma procedures) with patients receiving additional medications, at 1-year-post-treatment initiation. The study is a prospective, observational cohort study and will not provide or recommend any treatment. Patients who have failed initial medical therapy with two glaucoma medications will be identified and enrolled at the time of scheduling of a laser surgery procedure or other procedure such as incisional surgery or drainage device, or initiation of an additional course of therapy with medication as determined by their physician. This inception cohort of new initiators of laser surgical treatment, other procedures, or additional medical therapy will be followed for 12 months. All decisions regarding treatment are solely at the discretion of the physician in accordance with their usual practice. Enrollment is expected to begin in February 2011 and continue through 12 months of follow-up after enrollment targets have been reached.
Conditions Studied
Study Locations (1)
Pennsylvania
- Wills Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,597 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-07 |
What the finished NCT01645319 record still lists
NCT01645319 is an observational study that tracks outcomes without assigning an intervention. Its 2,597 participants enrollment target places it among the larger protocols in the corpus, above the 242-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (973% higher).
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01645319 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01645319 about?
NCT01645319 is a clinical study titled "Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma". The primary objectives of the study are: 1. To compare the proportion of patients who achieve a successful response to treatment (reduction in Intraocular Pressure (IOP) of \>15%) between patients treated with laser surgery (including argon laser trabeculectomy, and selective laser trabeculoplasty)...
What is the current status of trial NCT01645319?
This trial is currently completed. The enrollment target is 2,597 participants. The study started on 2011-02. Estimated completion is 2013-07.
What conditions does trial NCT01645319 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
Who is sponsoring clinical trial NCT01645319?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01645319 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01645319's enrollment target sits among peer trials
2,597 1st of 28 higher than 28 of 28 other Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
-
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia